Overexpression of the key Hh pathway regulators, SHH, DHH, PTCH1, and GLI1, in malignant tumors was found to be associated with proliferation, migration, metastasis, and aggressiveness of BC [183,184]. Here, GLI1 is linked to breast cancer.